Biology Reference
In-Depth Information
different PDE4 conformers down to the demanding identification of the COPD
population that most profit from a PDE4 inhibitor.
For all mentioned PDE inhibitors, further improvements seem to be desirable
and necessary. Relevant examples will be presented in several topic chapters and
finally, each successful development will represent one transient step on the path to
the future.
References
Allard E (1904) Uber Theocinvergiftung. Arch Klin Med 80:510-519
Alousi AA, Farah AE, Lesher GY, Opalka CJ (1979) Cardiotonic activity of amrinone-Win 40680
[5-amino-3, 4'-bipyridine-6(1H)-one]. Circ Res 45:666-677
American Thoracic Society (1962) Definitions and classifications of chronic bronchitis, asthma
and pulmonary emphysema. Am Rev Respir Dis 85:762-768
Andersson P (1980) Antigen-induced brochial anaphylaxis in actively sensitized guinea pigs.
Allergy 35:65-71
Au BT, Teixeira MM, Collins PD, Williams TJ (1998) Effect of PDE4 inhibitors on zymosan-
induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol.
Br J Pharmacol 123:1260-1266
Barnes PJ (1998) New therapies for chronic obstructive pulmonary disease. Thorax 53:137-147
Barnes PJ (2003a) Theophylline, new perspectives of an old drug. Am J Respir Crit Care Med
167:813-818
Barnes PJ (2003b) New concepts in chronic obstructive pulmonary disease. Annu Rev Med
54:113-129
Barnes PJ, Celli B (2008) Systemic manifestations and comorbidities of COPD. Eur Respir J
33:1665-1685
Barnes PJ, Rennard SI (2008) Pathophysiology of COPD. In: Barnes PJ, Drazen J, Rennard SI,
Thomson N (eds) Asthma and COPD. Basic mechanisms and clinical management. Academic,
Amsterdam, pp 425-442
Barnes AP, Livera G, Huang P, Sun C, O'Neal WK, Conti M, Stutts MJ, Milgram SL (2005)
Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway
epithelium. J Biol Chem 280:7997-8003
Barnette MS, Grous M, Cieslinski LB, Burman M, Christensen SB, Torphy TJ (1995a) Inhibitors
of phosphodiesterase IV (PDEIV) increase acid secretion in rabbit isolated gastric glands:
Correlation between function and interaction with a high-affinity rolipram binding site.
J Pharmacol Exp Ther 273:1396-1402
Barnette MS, Manning CD, Cieslinski LB, Burman M, Christensen SB, Torphy TJ (1995b) The
ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig
eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity. J Pharmacol
Exp Ther 273:674-679
Barnette MS, Bartus JO, Burman M, Christensen SB, Cieslinski LB, Esser KM, Prabhakar US,
Rush JA, Torphy TJ (1996) Association of the anti-inflammatory activity of phosphodiesterase
4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [
3
H]
rolipram binding. Biochem Pharmacol 51:949-956
Barnette MS, Christensen SB, Essayan DM, Grous M, Prabhakar U, Rush JA, Kagey-Sobotka A,
Torphy TS (1998) SB 207499 (Ariflo), a potent and selective second-generation phosphodies-
terase 4 inhibitor: in vitro anti-inflammatory actions. J Pharmacol Exp Ther 284:420-426
Beavo JA (1988) Multiple isozymes of cyclic nucleotide phosphodisterase. Adv Sec Messengers
Phosphoprotein Res 22:1-38
